Item 5.07 Submission of Matters to a Vote of Security Holders.

On October 21, 2022, Myovant Sciences Ltd. (the "Company") held its 2022 Annual General Meeting of Shareholders (the "Annual Meeting") in London, United Kingdom. At the Annual Meeting, the shareholders considered and approved three proposals, each of which is described in more detail in the Company's definitive proxy statement filed with the Securities and Exchange Commission on July 28, 2022 (the "Proxy Statement"). Set forth below are the voting results with respect to each matter voted upon.

Proposal No. 1, Election of Directors: Terrie Curran, Mark Guinan, Adele Gulfo, David Marek, Shigeyuki Nishinaka, Myrtle Potter, and Nancy Valente, M.D. were each elected to serve as a director for a one-year term by the following votes:



                                     Votes
       Name           Votes For     Against     Abstain   Broker Non-Votes
Terrie Curran         66,247,643   8,847,106    31,189       10,083,977
Mark Guinan           74,542,690    552,518     30,730       10,083,977
Adele Gulfo           62,528,003   12,565,075   32,860       10,083,977
David Marek           64,265,380   10,829,226   31,332       10,083,977
Shigeyuki Nishinaka   62,316,646   12,780,642   28,650       10,083,977
Myrtle Potter         62,402,073   12,696,196   27,669       10,083,977
Nancy Valente, M.D.   73,411,611   1,682,126    32,201       10,083,977

Proposal No. 2, Ratification of Selection of Auditors: The shareholders ratified the selection by the Audit Committee of the Company's Board of Directors of Ernst & Young LLP as the Company's independent registered public accounting firm for the Company's fiscal year ending March 31, 2023, the appointment of Ernst & Young LLP as the Company's auditor for statutory purposes under the Bermuda Companies Act 1981, as amended, for the Company's fiscal year ending March 31, 2023, and the authorization of the Company's Board of Directors, through the Audit Committee, to set the remuneration for Ernst & Young LLP as the Company's auditor for the Company's fiscal year ending March 31, 2023, by the following votes:



Votes For    Votes Against   Abstain   Broker Non-Votes
84,745,917      447,265      16,733           -

Proposal No. 3, Advisory Approval of Executive Compensation: The shareholders approved, on an advisory basis, the compensation of the Company's named executive officers, as described in the Proxy Statement, by the following votes:



Votes For    Votes Against   Abstain    Broker Non-Votes
68,808,308     5,909,941     407,689       10,083,977

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses